Market Place
Sourcing Support
bitBiome and Kaken sign agreement on discovery of drugs for infectious diseases
29 Mar 2023 //
PR NEWSWIRE
CymaBay Announces Collaboration with Kaken to Develop Seladelpar
08 Jan 2023 //
GLOBENEWSWIRE
Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan
05 Jan 2023 //
BUSINESSWIRE
Brickell Biotech Announces Initiation of a Ph1 Study of Sofpironium Bromide Gel
24 Jun 2021 //
GLOBENEWSWIRE
Numab Therapeutics and Kaken Form Co-Development Alliance for a Next
13 Jan 2021 //
NUMAB
Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan
25 Sep 2020 //
SEEKING ALPHA
Brickell Biotech Announces Issuance of Matter Patent on Sofpironium Bromide
31 Aug 2020 //
BIOSPACE
HitGen and Kaken Enter Into License Agreement
10 Mar 2020 //
BUSINESS WIRE
Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide
10 Jan 2020 //
GLOBE NEWSWIRE
HitGen, Kaken Pharma ink agreement to develop novel class of drugs
15 Apr 2019 //
PHARMABIZ
HitGen and Kaken Enter Into License Agreement
10 Apr 2019 //
BUSINESSWIRE
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Mylan
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Acrux DDS Pty Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Macleods Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Apotex Corp.
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Perrigo Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) :Valeant Pharmaceuticals vs. Teva Pharma USA
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole): Valeant Pharma, Dow Pharma, Kaken v. Aleor Dermaceutical
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Lupin
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Alkem Labs
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharmac v. Par Pharmaceutical
11 Sep 2018 //
PATENT LITIGATION
Valeant Announces Licensing Agreement With Kaken To Develop & Commercialize
28 Feb 2018 //
PR NEWSWIRE
Kaken signs agreement with Korea’s Dong-A ST for Clenafin/Jublia
01 Jun 2016 //
BIOSPECTRUM ASIA
